Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progestins and breast cancer

J R Pasqualini1, J Paris, R Sitruk-Ware

  • 1Hormones and Cancer Research Unit, Institut de Puériculture, Paris, France.

The Journal of Steroid Biochemistry and Molecular Biology
|August 12, 1998
PubMed
Summary

New progestins show promise in breast cancer treatment by inhibiting estrogen production. These compounds affect key enzymes, offering potential new therapeutic strategies for hormone-dependent cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sprint interval exercise disrupts mitochondrial ultrastructure driving a unique mitochondrial stress response and remodelling in men.

Nature communications·2025
Same author

Guardian of mitochondrial function: an expanded role of Parkin in skeletal muscle.

The Journal of physiology·2018
Same author

Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1/2 pathway.

British journal of pharmacology·2012
Same author

[Management of severe accidental hypothermia].

Medicina intensiva·2012
Same author

[Cardiac arrest due to accidental hypothermia and prolonged cardiopulmonary resuscitation].

Medicina intensiva·2010
Same author

The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.

Anticancer research·2008

Area of Science:

  • Endocrinology
  • Oncology
  • Medicinal Chemistry

Background:

  • Progestins are a class of steroid compounds with diverse structures and actions.
  • Their role in breast cancer treatment is an area of ongoing research, with limited clinical data but significant in vitro findings.
  • Understanding progestin mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • To explore the mechanisms of action of various progestins in breast cancer.
  • To investigate the effects of progestins on key enzymes involved in estrogen metabolism.
  • To assess the potential clinical applications of progestins in breast cancer therapy.

Main Methods:

  • In vitro studies using hormone-dependent and hormone-independent human mammary cancer cell lines.

Related Experiment Videos

  • Assays to evaluate the inhibitory effects of progestins on sulfatase and 17beta-hydroxysteroid dehydrogenase.
  • Analysis of progestin effects on mRNA expression of sulfatase.
  • Studies on the stimulation of sulfotransferase activity by progestins.

    • Main Results:

    • Several progestins (nomegestrol acetate, tibolone, medrogestone, promegestone) effectively inhibit sulfatase activity in hormone-dependent breast cancer cells.
    • Progestins also inhibit the 17beta-hydroxysteroid dehydrogenase enzyme, reducing estradiol formation from estrone.
    • Some progestins, like promegestone and medrogestone, stimulate sulfotransferase, promoting estrogen sulfate formation.

    Conclusions:

    • Progestins can block estradiol formation by inhibiting sulfatase and 17beta-hydroxysteroid dehydrogenase.
    • Progestins may offer new therapeutic avenues by modulating estrogen metabolism through sulfatase inhibition or sulfotransferase stimulation.
    • These findings suggest novel clinical applications for progestins in managing breast cancer.